Clinical Trial Update: Study of CM310 in Subjects With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for CM310 in subjects with seasonal allergic rhinitis is provided, with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: UNKNOWN